Published in J Virol on August 01, 1998
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol (1999) 4.99
Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol (2002) 4.06
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol (1999) 2.93
Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol (1999) 2.87
Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J (1999) 2.79
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol (2004) 2.69
Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol (2000) 2.66
The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology (2007) 2.54
Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol (2006) 2.41
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol (2002) 2.38
The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol (2004) 2.32
Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol (2000) 2.25
Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol (2004) 2.24
DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci U S A (2005) 2.20
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol (2001) 2.07
A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J (1998) 2.06
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol (2002) 2.04
Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol (1999) 2.04
Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J Virol (2004) 2.03
Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol (2007) 1.95
The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A (2001) 1.94
ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J Virol (2000) 1.90
Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol (1999) 1.84
Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A (2002) 1.82
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J (2010) 1.75
Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol (2010) 1.73
Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J Virol (2002) 1.67
Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. J Virol (1999) 1.66
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet (1998) 1.64
Nuclear sequestration of cellular chaperone and proteasomal machinery during herpes simplex virus type 1 infection. J Virol (2004) 1.63
Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO. J Virol (2001) 1.60
Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J Virol (2005) 1.54
Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J Virol (2009) 1.48
Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0. J Virol (2005) 1.47
A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog (2011) 1.47
SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A (2000) 1.47
PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J Virol (2003) 1.46
Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol (2003) 1.43
Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol (2003) 1.42
Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog (2016) 1.39
Snapshots: chromatin control of viral infection. Virology (2013) 1.39
The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog (2011) 1.37
PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci (2010) 1.35
Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol (2004) 1.34
Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. J Virol (2010) 1.32
Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog (2008) 1.31
Human pathogens and the host cell SUMOylation system. J Virol (2011) 1.31
Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J Virol (2008) 1.30
SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog (2011) 1.30
Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One (2010) 1.28
Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A (2009) 1.27
Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J Virol (2004) 1.27
Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol (2013) 1.26
Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol (2006) 1.24
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol (2008) 1.22
Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci U S A (2001) 1.21
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog (2008) 1.20
Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. J Virol (2001) 1.17
Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol (2012) 1.16
Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol (2012) 1.16
Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J Virol (2003) 1.15
EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog (2011) 1.14
The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J Virol (2013) 1.14
Differential Roles of PML Isoforms. Front Oncol (2013) 1.13
A novel cell response triggered by interphase centromere structural instability. J Cell Biol (2007) 1.11
Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol (2008) 1.10
Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments. J Virol (2001) 1.09
Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol (2011) 1.09
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol (2010) 1.08
The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J Virol (2002) 1.08
Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. J Virol (2007) 1.08
Nucleolin is required for an efficient herpes simplex virus type 1 infection. J Virol (2008) 1.07
Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J Virol (2009) 1.07
Herpesviral replication compartments move and coalesce at nuclear speckles to enhance export of viral late mRNA. Proc Natl Acad Sci U S A (2011) 1.06
ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger. J Virol (2006) 1.06
Functional inaccessibility of quiescent herpes simplex virus genomes. Virol J (2005) 1.06
Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection. J Virol (2004) 1.06
Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain. Mol Cell (2012) 1.06
Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1. J Virol (2011) 1.05
Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 induce the formation of colocalizing, conjugated ubiquitin. J Virol (2001) 1.04
Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol (2002) 1.03
Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J Virol (2007) 1.03
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies. Viruses (2009) 1.03
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol (2012) 1.03
Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. MBio (2011) 1.02
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 9.40
A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell (1997) 9.01
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol (1996) 7.64
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol (1986) 6.74
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell (1994) 6.52
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol (1995) 5.74
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol (1987) 5.71
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J (1994) 4.61
Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol (1993) 4.32
The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol (1994) 4.32
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J (1994) 4.29
Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol (1997) 4.26
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91
Identification of a novel nuclear domain. J Cell Biol (1991) 3.91
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci (1992) 3.91
PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene (1996) 3.73
Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev (1996) 3.63
Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology (1996) 3.62
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science (1991) 3.57
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res (1996) 3.37
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 3.34
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol (1989) 2.97
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol (1997) 2.83
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol (1995) 2.82
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol (1989) 2.76
Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts. Methods Cell Biol (1991) 2.76
Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol (1997) 2.70
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.54
RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc Natl Acad Sci U S A (1997) 2.42
Roles of ubiquitinylation in proteolysis and cellular regulation. Annu Rev Nutr (1995) 2.26
Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol (1996) 2.25
A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol (1991) 2.25
A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology (1993) 2.21
Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 2.15
Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology (1995) 2.14
RCC1, a regulator of mitosis, is essential for DNA replication. Mol Cell Biol (1992) 2.08
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol (1997) 2.06
Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology (1994) 2.06
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol (1995) 1.92
Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J Cell Biochem (1995) 1.86
Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr Biol (1998) 1.86
Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem (1997) 1.80
SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem Sci (1997) 1.79
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J Virol (1997) 1.72
Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem (1997) 1.71
SUMO-1: Ubiquitin gains weight. Trends Cell Biol (1997) 1.68
Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol (1995) 1.67
The 65 K DNA binding protein appears early in HSV-1 replication. Arch Virol (1988) 0.92
Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies. J Cell Sci (1997) 0.90
THE SYNDROME OF SHORT P-R INTERVAL, APPARENT BUNDLE BRANCH BLOCK, AND ASSOCIATED PAROXYSMAL TACHYCARDIA. Br Heart J (1940) 13.19
ATRIAL SEPTAL DEFECT. Br Heart J (1941) 10.04
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (1999) 5.99
p47 is a cofactor for p97-mediated membrane fusion. Nature (1997) 4.02
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 3.34
DIGITALIS IN HEART FAILURE WITH NORMAL RHYTHM. Br Heart J (1939) 3.00
CENP-C is required for maintaining proper kinetochore size and for a timely transition to anaphase. J Cell Biol (1994) 2.86
Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer (1984) 2.78
The ran GTPase regulates mitotic spindle assembly. Curr Biol (1999) 2.66
Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell (1998) 2.54
RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc Natl Acad Sci U S A (1997) 2.42
Distant metastasis of renal adenocarcinoma. Cancer (1981) 2.27
A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology (1993) 2.21
Evidence for a dual role for TC4 protein in regulating nuclear structure and cell cycle progression. J Cell Biol (1994) 2.17
Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology (1995) 2.14
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem (1991) 2.07
A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J (1998) 2.06
Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology (1994) 2.06
The effect of inhalation of oxygen on the rate of the pulse in health. J Physiol (1912) 2.05
Cell cycle regulation of PML modification and ND10 composition. J Cell Sci (1999) 2.04
Identification of overlapping DNA-binding and centromere-targeting domains in the human kinetochore protein CENP-C. Mol Cell Biol (1996) 1.99
Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) N Engl J Med (1992) 1.99
Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr Biol (1998) 1.86
Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem (2000) 1.84
Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J Virol (1988) 1.81
The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res (2000) 1.80
SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem Sci (1997) 1.79
An NSF function distinct from ATPase-dependent SNARE disassembly is essential for Golgi membrane fusion. Nat Cell Biol (1999) 1.76
A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. J Mol Biol (1993) 1.68
Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol (1982) 1.65
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 1.65
Electrical and mechanical alternans in canine myocardium in vivo. Dependence on intracellular calcium cycling. Circulation (1993) 1.62
Chromatin transitions during early Xenopus embryogenesis: changes in histone H4 acetylation and in linker histone type. Dev Biol (1993) 1.58
A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem (2000) 1.56
Cytosolic HSP90 and HSP70 are essential components of INF1-mediated hypersensitive response and non-host resistance to Pseudomonas cichorii in Nicotiana benthamiana. Mol Plant Pathol (2003) 1.52
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol (2001) 1.52
High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. Nucleic Acids Res (1991) 1.51
Multicenter evaluation of a colorimetric microplate antimycobacterial susceptibility test: comparative study with the NCCLS M24-P. Rinsho Byori (1996) 1.48
Swinepox in pigs in northern Western Australia. Aust Vet J (1992) 1.47
The human RAE1 gene is a functional homologue of Schizosaccharomyces pombe rae1 gene involved in nuclear export of Poly(A)+ RNA. Gene (1997) 1.45
Exercise-induced anaphylaxis: improvement after removal of amalgam in dental caries. Ann Allergy (1990) 1.44
On the coupling between DNA replication and mitosis. J Cell Sci Suppl (1989) 1.44
The ran decathlon: multiple roles of Ran. J Cell Sci (2000) 1.42
COMMON AORTO-PULMONARY TRUNK: A RARE CONGENITAL DEFECT. Br Heart J (1943) 1.41
A Memorandum UPON HEART AFFECTIONS IN SOLDIERS: WITH SPECIAL REFERENCE TO PROGNOSIS OF "IRRITABLE HEART.". Br Med J (1916) 1.38
A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J Biol Chem (1999) 1.38
Overexpression of Bax inhibitor suppresses the fungal elicitor-induced cell death in rice (Oryza sativa L) cells. Plant J (2003) 1.37
Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol (2000) 1.33
Unique activity associated with non-insecticidal Bacillus thuringiensis parasporal inclusions: in vitro cell-killing action on human cancer cells. J Appl Microbiol (1999) 1.32
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood (1997) 1.31
Dual cellulose-digesting system of the wood-feeding termite, Coptotermes formosanus Shiraki. Insect Biochem Mol Biol (2002) 1.31
A spontaneously ruptured gastric stromal tumor presenting as generalized peritonitis: report of a case. Surg Today (2001) 1.29
[Giant testicular tumor associated with scrotal gangrene: a case report]. Hinyokika Kiyo (1997) 1.26
Serial Analysis of Gene Expression (SAGE) of Magnaporthe grisea: genes involved in appressorium formation. Mol Genet Genomics (2003) 1.26
Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J (2001) 1.25
Virus-induced silencing of WIPK and SIPK genes reduces resistance to a bacterial pathogen, but has no effect on the INF1-induced hypersensitive response (HR) in Nicotiana benthamiana. Mol Genet Genomics (2003) 1.25
Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. Nucleic Acids Res (1991) 1.25
Bitter taste transduced by PLC-beta(2)-dependent rise in IP(3) and alpha-gustducin-dependent fall in cyclic nucleotides. Am J Physiol Cell Physiol (2001) 1.25
Direct and indirect association of the small GTPase ran with nuclear pore proteins and soluble transport factors: studies in Xenopus laevis egg extracts. Mol Biol Cell (1996) 1.25
Rapid kinetics of second messenger production in bitter taste. Am J Physiol (1996) 1.22
Primary retroperitoneal ganglioneuroblastoma in an adult. Int J Urol (2001) 1.22
Structure and distribution of specific cis-elements for transcriptional regulation of PHO84 in Saccharomyces cerevisiae. Mol Gen Genet (1995) 1.20
What is the harm-benefit ratio of Cox-2 inhibitors? Int J Epidemiol (2008) 1.16
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther (2000) 1.15
Parasporin, a human leukemic cell-recognizing parasporal protein of Bacillus thuringiensis. Clin Diagn Lab Immunol (2000) 1.15
Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14. Nature (1989) 1.13
Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1. J Biol Chem (2000) 1.13
The role of Ran in nuclear function. Curr Opin Cell Biol (2000) 1.12
The promyelocytic leukemia protein stimulates SUMO conjugation in yeast. Oncogene (2006) 1.11
A dynamic connection between centromeres and ND10 proteins. J Cell Sci (1999) 1.07
Metastatic processes and a potential indication of treatment for metastatic lesions of renal adenocarcinoma. J Urol (1982) 1.07
Effort Syndrome in Soldiers. Br Med J (1941) 1.07
Out of hours workload in general practice: deprivation or expectation? BMJ (1990) 1.06
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. Br J Haematol (1999) 1.05
Identification of the bud emergence gene BEM4 and its interactions with rho-type GTPases in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.04
Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state. J Gen Virol (1985) 1.03
A family of secreted mucins from the parasitic nematode Toxocara canis bears diverse mucin domains but shares similar flanking six-cysteine repeat motifs. J Biol Chem (2000) 1.03
Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation (1999) 1.02
Distant metastasis of renal adenocarcinoma in patients with a tumor thrombus in the renal vein and/or vena cava. J Urol (1982) 1.02
An epitope within the DNA-binding domain of the herpes simplex virus immediate early protein Vmw175 is conserved in the varicella-zoster virus gene 62 protein. J Gen Virol (1993) 1.01
Mutagenesis of acidic residues in the oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding. Biochemistry (1997) 1.01
Pneumatosis cystoides intestinalis after chemotherapy for hematological malignancies: report of 4 cases. Intern Med (1995) 1.00
Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol Pharmacol (1995) 1.00
Cellular proteins expressed in herpes simplex virus transformed cells also accumulate on herpes simplex virus infection. EMBO J (1985) 0.99
The Vmw175 binding site in the IE-1 promoter has no apparent role in the expression of Vmw110 during herpes simplex virus type 1 infection. Virology (1991) 0.99
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol (2000) 0.98
Arterial stiffness independently predicts cardiovascular events in an elderly community -- Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother (2005) 0.98
Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol (1998) 0.98
Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs. J Mol Biol (1991) 0.98